Studies of COVID-19 patients also showed significant increases in proinflammatory cytokines and chemokines, including IL-6, IL-1β, TNF-α, and granulocyte–macrophage colony-stimulating factor, in patients’ plasma, with much higher levels in the plasma of critically ill patients [40]. The gene discussed is IL6; the disease is COVID-19.